Juventas Therapeutics

Developer of non-viral gene therapies to treat cardiovascular diseases that target natural repair pathways

placeCleveland, Ohio, United States calendar_todayFounded 2007 groups1 employees language juventasinc.com

Registered entities

Innovation

6 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 990 times.

YearFilings
20132
20145
20155
20164
20174
20182
20191

Investor mix

19 investors on record; lead investors include Green Cross, POSCO Capital, CICC, Triathlon Medical Ventures.

Investor typeCountShare
Venture capital1158%
Accelerator & incubator316%
Bank & private debt211%
Other / undisclosed316%
Coming soon